Global Gene Panel Market Is Growing At CAGR Of 23.4% To Reach USD 6,900.8 Million By 2027

April 2021 | Report Format: Electronic (PDF)

The worldwide industry is generating pace as a result of technological improvements, the accessibility of fast diagnostic tools, as well as the significant growth in various types of malignancies in nations throughout the world. To address the increased incidence of cancer, numerous pharmaceutical firms are funding in r&d to produce more advanced personalized cancer medicines. These firms' high need for genetic arrays to research and deploy tailored cancer medicines is driving the gene panel industry's sales growth. Furthermore, the rise in illnesses caused by genetic variation has raised the market for gene panel screening.

The worldwide gene panel industry is predicted to grow significantly owing to an increase in the incidence of acute illnesses throughout the world. Furthermore, a rise in the frequency of corporate efforts throughout the globe, as well as the advantages of gene arrays, are important drivers expected to boost the gene panel industry throughout the projected timeframe. Rigorous laws and restrictions for pharmaceutical businesses, as well as security concerns over genomics information, are expected to stymie the gene panel industry in the approaching years. However, continuous study and progress in the area of genetic analysis are likely to give considerable prospects for business growth throughout the projected timeline.

North America's industry accounts for the biggest profit position in the worldwide gene panel industry in 2020 and therefore is predicted to lead the various international market throughout the projected timeline. Variables including the growing frequency of chronic as well as contagious illnesses, cancer, the influence of several significant competitors, and increased regulatory assistance for genomics study are driving a higher market for gene arrays in the territory.

Request a Free Sample Copy: Gene Panel Market Report

Gene Panel Market Report Highlights

• Bionano Genomics, an American genome testing business, confirmed the debut of EpiPanelDx PLUS, a genetic panels testing for epilepsy detection, in September 2020.
• Thermo Fisher Scientific released Ion AmpliSeq HD technologies in June 2018 for a next collection that would empower clinical investigators with the custom-designed genetic panel to examine extremely diverse tumor specimens.
• In October 2019, Illumina, Inc., a U.S biotechnology firm, and QIAGEN, a German genetic diagnostics business, launched a 15-year collaboration to increase the availability of next-generation alignment clinical diagnostics used in genetic panels.

GENE PANEL MARKET SEGMENTATION

The research report published by Market Research Strategy contains industry segments, as below-

Gene Panel Product and Service Outlook (Revenue, USD Million, 2016 - 2027)

• Test Kits
• Testing Services

Gene Panel Technique Outlook (Revenue, USD Million, 2016 - 2027)

• Amplicon-based Approach
• Hybridization-based Approach

Gene Panel Application Outlook (Revenue, USD Million, 2016 - 2027)

• Diagnosis of Congenital Diseases
• Cancer Risk Assessment
• Pharmacogenetics
• Others

Gene Panel End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Diagnostic Laboratories
• Pharmaceutical Companies
• Others

Gene Panel Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America (U.S., and Canada)
• Europe (Germany, U.K., France, Italy, Spain etc.)
• Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
• South America (Brazil, Mexico, Argentina etc.)
• Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

List of Key Players- Gene Panel Market

• Illumina
• Agilent Technologies
• ArcherDx
• BGI
• CENTOGENE AG
• Eurofins Scientific
• F. Hoffmann-La Roche AG
• GATC Biotech AG
• GeneDx Inc.
• GENEWIZ, Inc.
• Illumina
• Integrated DNA Technologies
• Invitae Corporation
• Novogene Corporation
• Personalis
• QIAGEN
• Thermo Fisher Scientific

About Market Research Strategy:

Market Research Strategy (MRS) is a dedicated and disciplined market research firm that delivers authentic consulting services with accurate data forecasting for research-related services. The positive and result-oriented approaches implemented by us are beneficial in identifying the market challenges of any brand or start-up company to penetrate the competitive business space.

MRS also supports numerous organizations with its syndicate data and research reports to establish and survive in the market by grabbing the available market opportunities. Our vast experience and huge client database turn out to be our wealth and also secures our market position at the top of the list. Besides, we make use of every single piece of information, mined from authentic sources, into a valuable asset of the report; aiding our clients with informed business decisions.

Contact Us:

Market Research Strategy
USA Phone: +1 9176726599

Business Email: sales@marketresearchstrategy.com

Website: https://marketresearchstrategy.com/